GT200600016A - PHARMACEUTICAL COMPOUNDS - Google Patents

PHARMACEUTICAL COMPOUNDS

Info

Publication number
GT200600016A
GT200600016A GT200600016A GT200600016A GT200600016A GT 200600016 A GT200600016 A GT 200600016A GT 200600016 A GT200600016 A GT 200600016A GT 200600016 A GT200600016 A GT 200600016A GT 200600016 A GT200600016 A GT 200600016A
Authority
GT
Guatemala
Prior art keywords
pharmaceutical compounds
compounds
cycline
tautomers
solvates
Prior art date
Application number
GT200600016A
Other languages
Spanish (es)
Inventor
Valerio Berdini
Adrian Liam Gill
Eva Figueroa Navarro
Michael Alistair O'brien
Theresa Rachel Philips
Gary Trewartha
Andrew James Woodhead
Paul Graham Wyatt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0501480A external-priority patent/GB0501480D0/en
Priority claimed from GB0501748A external-priority patent/GB0501748D0/en
Application filed filed Critical
Publication of GT200600016A publication Critical patent/GT200600016A/en

Links

Abstract

LA INVENCIÓN SE REFIERE A COMPUESTOS DE FÓRMULA I, O SUS SALES, TAUTÓMEROS, N-ÓXIDOS O SOLVATOS DE LOS MISMO. DICHOS COMPUESTOS TIENEN ACTIVIDAD COMO INHIBIDORES DE LA QUINASA DEPEDIENTE DE CICLINA E INHIBEN LA PROLIFERACIÓN DE CÉLULAS DE CÁNCER.THE INVENTION REFERS TO COMPOUNDS OF FORMULA I, OR ITS SALTS, TAUTOMERS, N-OXIDES OR SOLVATES OF THE SAME. THESE COMPOUNDS HAVE ACTIVITY AS INHIBITORS OF THE CYCLINE DEPEDENT KINASE AND INHIBIT THE PROLIFERATION OF CANCER CELLS.

GT200600016A 2005-01-21 2006-01-11 PHARMACEUTICAL COMPOUNDS GT200600016A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US64621705P 2005-01-21 2005-01-21
GB0501480A GB0501480D0 (en) 2005-01-22 2005-01-22 Pharmaceutical compounds
GB0501748A GB0501748D0 (en) 2005-01-27 2005-01-27 Pharmaceutical compounds
US65133905P 2005-02-09 2005-02-09

Publications (1)

Publication Number Publication Date
GT200600016A true GT200600016A (en) 2006-08-09

Family

ID=45699652

Family Applications (3)

Application Number Title Priority Date Filing Date
GT200600015A GT200600015A (en) 2005-01-21 2006-01-11 PHARMACEUTICAL COMPOUNDS
GT200600014A GT200600014A (en) 2005-01-21 2006-01-11 PHARMACEUTICAL COMPOUNDS
GT200600016A GT200600016A (en) 2005-01-21 2006-01-11 PHARMACEUTICAL COMPOUNDS

Family Applications Before (2)

Application Number Title Priority Date Filing Date
GT200600015A GT200600015A (en) 2005-01-21 2006-01-11 PHARMACEUTICAL COMPOUNDS
GT200600014A GT200600014A (en) 2005-01-21 2006-01-11 PHARMACEUTICAL COMPOUNDS

Country Status (3)

Country Link
GT (3) GT200600015A (en)
MY (1) MY139848A (en)
TW (3) TW200637858A (en)

Also Published As

Publication number Publication date
TW200640922A (en) 2006-12-01
GT200600014A (en) 2006-08-09
GT200600015A (en) 2006-08-09
TW200639170A (en) 2006-11-16
TW200637858A (en) 2006-11-01
MY139848A (en) 2009-11-30

Similar Documents

Publication Publication Date Title
SMT201300109B (en) Imidazopyridazincarbonitriles useful as kinase inhibitors
ATE400567T1 (en) KINASE INHIBITORS
CR20110028A (en) PIRIMIDINE DERIVATIVES AS CINASE INHIBITORS
EA200971051A1 (en) INHIBITORS P70 S6 KINASE
ECSP088450A (en) DERIVATIVES OF PYRIMIDINE 4- (3-AMINOPIRAZOL) FOR USE AS INHIBITORS OF THYROSINE KINASE IN CANCER TREATMENT
NO20073921L (en) Triazoloftalaziner
EA200801428A1 (en) PYRIDIAZINONE DERIVATIVES FOR THE TREATMENT OF TUMORS
DK2134691T3 (en) QUINOLINONDERIVATIVES AS PARP AND TANK INHIBITORS
CU20070160A7 (en) PIRROLOPIRAZOLES, POWERFUL QUINASA INHIBITORS
MX2009011210A (en) 7-nonsubstituted indole mcl-1 inhibitors.
MX2009011211A (en) 7-substituted indole mcl-1 inhibitors.
NI201000059A (en) C-FMS KINASE INHIBITORS.
SG178591A1 (en) Jak2 inhibitors and their use for the treatment of myeloproliferative diseases and cancer
NO20081454L (en) Met kinase inhibitors
CR11333A (en) cis-IMIRAZOLINAS QUIRALES
EA200901488A1 (en) SUBSTITUTED IMIDAZOLOPIRIDAZINES AS LIPIDKINASE INHIBITORS
EA201390609A1 (en) HIDANTOIN DERIVATIVES USEFUL AS KV3-CHANNEL INHIBITORS
PA8667201A1 (en) NEW PHARMACEUTICAL COMPOUNDS
EA201170531A1 (en) COMPOUNDS BASED ON Pyridine and Pyrimidine as WNT Signal Inhibitors for Cancer Treatment
UA85505C2 (en) Kinase inhibitors
ECSP099722A (en) PIRIDO COMPOUNDS [2, 3-D] PIRIMIDINA-7-ONA AS PI3K-ALFA INHIBITORS FOR CANCER TREATMENT
UA107689C2 (en) 3,4,4A,10B-TETRAHYDRO-1H-THIOPYRANO-[4, 3-c] ISOQUINOLINE DERIVATIVES
CL2013002602A1 (en) Compounds derived from [(pyridinyl or pyrazinyl) -methyloxy] - (phenyl or pyridine) substituted with a benzo-condensed system, inhibitors of spleen tyrosine kinase (syk); pharmaceutical composition and combination; and use in the treatment of an autoimmune disease.
EA200800070A1 (en) DERIVATIVES OF 2- (1H-INDOLYLSULFANIL) ARYLAMINE
CR20120502A (en) USE OF NEW PAN-CDK INHIBITORS TO TREAT TUMORS